Elena Prokupets is Director at C4 Therapeutics, Inc. (CCCC). They have made 7 open-market trades across 1 company since 2021, most recently 2021-09-27.
CIK 0001824823
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 7 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CCCC | 31,681 | $88K |
Shares reported on the most recent Form 4, priced at the 2021-09-29 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CCCC | SELL | 2021-09-27 | 2021-09-29 | $50.04 | $158K | -10.3% | -4.7% | -29.5% |
| CCCC | SELL | 2021-09-22 | 2021-09-24 | $50.27 | $3.2M | -8.4% | -9.5% | -31.6% |
| CCCC | SELL | 2021-09-17 | 2021-09-21 | $50.09 | $2.1M | -8.4% | -12.3% | -37.2% |
| CCCC | SELL | 2021-09-14 | 2021-09-16 | $48.78 | $6.4M | -0.8% | -13.9% | -38.9% |
| CCCC | SELL | 2021-09-10 | 2021-09-14 | $50.05 | $527K | -0.1% | -10.1% | -34.0% |
| CCCC | SELL | 2021-08-03 | 2021-08-05 | $45.16 | $1.3M | -4.1% | +14.2% | +13.3% |
| CCCC | SELL | 2021-07-29 | 2021-08-02 | $45.00 | $893K | -11.5% | -6.2% | +2.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.